Zobrazeno 1 - 10
of 17
pro vyhledávání: '"John H. Peniston"'
Autor:
John H. Peniston
Publikováno v:
The Physician and Sportsmedicine. 40:21-32
Up to 30% of athletes experience low back pain (LBP) depending on sport type, sex, training intensity and frequency, and technique. United States clinical guidelines define back pain as chronic if it persists for ≥ 12 weeks, and subacute if it pers
Publikováno v:
Postgraduate Medicine. 124:114-122
Opioids and antidepressants are frequently prescribed for chronic low back pain (cLBP). This post hoc analysis was conducted to assess the tolerability of oxymorphone extended release (ER) for cLBP in patients taking selective serotonin reuptake inhi
Publikováno v:
Therapeutics and Clinical Risk Management
John H Peniston,1 Morris S Gold,2 Matthew S Wieman,3 Lawrence K Alwine41Feasterville Family Health Care Center, Feasterville, PA, 2Novartis Consumer Health, Inc, Parsippany, NJ, 3Endo Pharmaceuticals Inc, Malvern, PA, 4Downingtown Family Medicine, Do
Publikováno v:
Clinical Interventions in Aging
John H Peniston,1 Morris S Gold,2 Matthew S Wieman,3 Lawrence K Alwine41Feasterville Family Health Care Center, Feasterville, PA, 2Clinical Research and Biostatistics, Novartis Consumer Health Inc, Parsippany, NJ, 3Medical Affairs, Endo Pharmaceutica
Autor:
John H. Peniston
Publikováno v:
Low Back Pain Pathogenesis and Treatment
Chronic low back pain is a common, debilitating, and costly health problem (Centers for Disease Control and Prevention, 2001; Collins et al., 2005; Mapel et al., 2004; Vogt et al., 2005). The prevalence of chronic low back pain is higher in women and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc87fdd0c4e275a60582771e11db7d57
https://doi.org/10.5772/35841
https://doi.org/10.5772/35841
Publikováno v:
The Physician and sportsmedicine. 39(3)
To evaluate the long-term safety and tolerability of topical diclofenac sodium 1% gel (DSG) in the treatment of knee osteoarthritis (OA) for up to 12 months.This was a multicenter open-label, extension of two 3-month, randomized, double-blind studies
Autor:
Roy D. Altman, Matthew S. Wieman, Richard A. Petruschke, Morris S. Gold, John H. Peniston, Edward Huskisson, Grigorios Fotopoulos
Publikováno v:
PM&R. 3
Publikováno v:
PM&R. 3
Publikováno v:
PM&R. 3
Publikováno v:
Current medical research and opinion. 26(8)
To evaluate the influence of age, sex, and previous opioid experience on the likelihood of successfully titrating opioid-naive and experienced patients with chronic low back pain (CLBP) to an effective and well-tolerated dose of oxymorphone extended